Perbedaan Cipta Sarana Medika Tbk. dan Unilever Indonesia Tbk.: Cipta Sarana Medika Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 158,12 M, volume 24 jam 8,21 jt), sedangkan Unilever Indonesia Tbk. diperdagangkan di Rp1.670 (kapitalisasi pasar 63,9 T, volume 24 jam 9,09 jt). Perbedaan utamanya: Unilever Indonesia Tbk. jauh lebih besar — sekitar 404,1× kapitalisasi pasar Cipta Sarana Medika Tbk., dan Unilever Indonesia Tbk. lebih aktif diperdagangkan (9,09 jt vs 8,21 jt). Mana yang lebih baik tergantung tujuan investasimu.
| DKHH | UNVR | |
|---|---|---|
Kapitalisasi Pasar | 158,12 M | 63,9 T |
Volume | 8,21 jt | 9,09 jt |
Lot | 82,15 rb | 90,94 rb |
Perputaran | 515,2 jt | 15,25 M |
Harga Rata-rata | 62,72 | 1.677,47 |
Nilai Transaksi | 515,2 jt | 15,25 M |
Harga Ekuilibrium Indikatif | 63 | 1.670 |
Volume Ekuilibrium Indikatif | 1,33 rb | 3,26 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →PT Unilever Indonesia Tbk (the Company) was established on 5 December 1933 as Levers Zeepfabrieken N.V. by deed No. 23 of Mr. A.H. van Ophuijsen, a notary in Batavia, which was approved by the Gouverneur Generaal van Nederlandsch-Indie in letter No. 14 on 16 December 1933, registered at the Raad van Justitie in Batavia under No. 302 on 22 December 1933 and published in the Javasche Courant on 9 January 1934, Supplement No. 3.
Selengkapnya di halaman UNVR →